- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01643538
Social Goals and Individual Incentives to Promote Walking in Older Adults
Social Goals and Individual Incentives to Promote Walking in Older Adults (Way to Walk II)
Panoramica dello studio
Stato
Condizioni
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Stati Uniti, 19104
- University of Pennsylvania
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Adult 65 years of age and older
- Can read and speak English
- Access to a personal computer with high-speed internet connection and functional Universal Serial Bus (USB) port for the study duration
- Able to walk 1/4 mile (i.e., 2 to 3 blocks) without stopping
- No pedometer use in last 30 days
Exclusion Criteria:
Major medical conditions including:
- serious heart and lung diseases
- diabetes requiring insulin therapy
- severe arthritis
- neurologic disorders
- dementia
- heavy alcohol use
- recent knee or spinal surgery
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Ricerca sui servizi sanitari
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Control Arm
Daily use of pedometer for 5 months. Walking goal set based on level of walking during 2-week run-in period. Weekly feedback provided on meeting walking goal - defined as achieving goal number of steps for 5 of 7 days per week. Subjects in the Control Group will only receive pedometers and weekly feedback on their performance through the same mechanisms and with the same frequency as participants in the other three study arms. There will be no financial incentives or charity donations in this group. |
Daily use of pedometer for 5 months.
Walking goal set based on level of walking during 2-week run-in period.
Weekly feedback provided on meeting walking goal - defined as achieving goal number of steps for 5 of 7 days per week.
|
|
Sperimentale: Personal Financial Incentives Arm
Daily use of pedometer for 5 months.
Walking goal set based on level of walking during 2-week run-in period.
Weekly feedback provided on meeting walking goal - defined as achieving goal number of steps for 5 of 7 days per week.
Each week, if pedometer is used and walking goal is met for 5 out of 7 days, participant will receive $20. Financial incentive is terminated after 4 months.
Daily use of pedometer continues for an additional 4 weeks.
|
Daily use of pedometer for 5 months.
Walking goal set based on level of walking during 2-week run-in period.
Weekly feedback provided on meeting walking goal - defined as achieving goal number of steps for 5 of 7 days per week.
Participants will receive a direct financial incentive in the amount of $20 for each week when their daily pedometer step count equals or exceeds their goal at least 5 out of 7 days.
|
|
Sperimentale: Social Goals Arm
Daily use of pedometer for 5 months.
Walking goal set based on level of walking during 2-week run-in period.
Weekly feedback provided on meeting walking goal - defined as achieving goal number of steps for 5 of 7 days per week.
Each week participants will be asked to designate which charity should receive a donation if they meet or exceed their goal.
If they meet the goal, they will be notified that a donation of $20 in their name has been sent to the charity.
Charity donation is terminated after 4 months.
Daily use of pedometer continues for an additional 4 weeks.
|
Daily use of pedometer for 5 months.
Walking goal set based on level of walking during 2-week run-in period.
Weekly feedback provided on meeting walking goal - defined as achieving goal number of steps for 5 of 7 days per week.
Participants will be asked to identify a charity to which they would like to donate the payment for reaching their walking goal.
Each week they will be asked to designate which charity should receive a donation if they meet or exceed their goal.
If they meet the goal, they will be notified that a donation of $20 in their name has been sent to the charity.
|
|
Sperimentale: Combined Financial Incentives & Social Goals Arm
Daily use of pedometer for 5 months.
Walking goal set based on level of walking during 2-week run-in period.
Weekly feedback provided on meeting walking goal - defined as achieving goal number of steps for 5 of 7 days per week.
Each week, the participant will be asked to choose whether to keep, give, or split the reward, if they meet or exceed their goal.
If they choose to send some of the money to charity, they will be asked to identify a charity to which they would like to donate the payment.
If they meet their goal, they will receive money and/or be notified that a donation of the selected amount has been sent to the charity, depending on their selected preference.
Incentives are terminated after 4 months.
Daily use of pedometer continues for an additional 4 weeks.
|
Daily use of pedometer for 5 months.
Walking goal set based on level of walking during 2-week run-in period.
Weekly feedback provided on meeting walking goal - defined as achieving goal number of steps for 5 of 7 days per week.
Participants will be able to allocate their reward for reaching their walking goal: the $20 reward can be divided between personal financial incentive and a charitable donation.
Each week, the participant will be asked to choose whether to keep, give, or split the reward, if they meet or exceed their goal.
If they choose to send some of the money to charity, they will be asked to identify a charity to which they would like to donate the payment.
If they meet their goal, they will be notified by email or mail (based on their preference), that a donation of the selected amount has been sent to the charity.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
mean proportion of days that step per day goals were attained
Lasso di tempo: 16 weeks
|
16 weeks
|
Misure di risultato secondarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
mean number of steps per day
Lasso di tempo: 16 weeks
|
16 weeks
|
|
mean proportion of days that step per day goals were attained during follow-up
Lasso di tempo: 4 weeks
|
4 weeks
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Karen Glanz, PhD, MPH, University of Pennsylvania
- Investigatore principale: Jason Karlawish, MD, University of Pennsylvania
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- 69924
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .